Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide

NCT00421694 is registered in ClinicalTrials.gov with University of L'Aquila as lead sponsor.

NCT NCT00421694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
Lead sponsor
University of L'Aquila
Phase
Phase 2/3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
119
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer